Anvisa updates the Reference Medicines List.

Anvisa atualiza Lista de Medicamentos de Referência

Anvisa has updated the The Reference Medicines List. The list is divided into groups that organize medicines based on their composition. Check the description of each group:

  • Group A: Refers to medicines containing a single active pharmaceutical ingredient.
  • Group B: Includes medicines with two or more active pharmaceutical ingredients, but in a single pharmaceutical form.
  • Group C: Includes medicines with two or more active pharmaceutical ingredients, in the same or different pharmaceutical forms, for concomitant or sequential use.

Furthermore, to access the latest versions of the lists, see the updates below:

This information is important for those who want to understand the different categories of medicines on the reference list.

If you need more information on regulatory matters regarding the pharmaceutical sector, ELS can help.

Please contact your local ELS consultant or email us at info@elssolutions.pt.

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.